Back to results
US 2021/0228587 A1Published application
Preservative free brimonidine and timolol solutions
AssigneeAllergan, Inc.
InventorsSukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly
Life of this patent
Estimating the term…
Abstract
The present invention is directed to preservative-free solutions of brimonidine and timolol for lowering intra-ocular pressure and treatment of glaucoma.
Claims10
1) A preservative free brimonidine and timolol composition for lowering intraocular pressure in a human patient comprising the following formulation:
- about 0.2% w/v brimonidine;
- about 0.5% w/v timolol;
- about 2.15% w/v sodium phosphate dibasic heptahydrate;
- water and at a pH of about 6.9.
1 more element
2) A preservative free brimonidine and timolol composition for lowering intraocular pressure in a human patient comprising the following formulation:
- 0.2% w/v brimonidine;
- 0.5% w/v timolol;
- about 2.15% w/v sodium phosphate dibasic heptahydrate;
- hydrochloric acid, sodium hydroxide, and water and at a pH of about 6.9.
1 more element
4) A composition as described in Table 1.
Dependencies are inferred from the claim text.